Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
- A. M. Fichtinger-Schepman, J. L. van der Veer, J. H. den Hartog, P. H. Lohman, J. Reedijk
- Chemistry, Medicine
- Biochemistry
- 29 January 1985
Salmon sperm DNA, treated with the antitumor agent cis-diamminedichloroplatinum(II) (cis-DDP), was enzymatically degraded to (oligo)nucleotides. Four Pt-containing products were identified by 1H NMR… Expand
cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose…
- A. M. Fichtinger-Schepman, A. V. van Oosterom, P. H. Lohman, F. Berends
- Chemistry, Medicine
- Cancer research
- 1 June 1987
The same four platinum-containing products identified in nucleolytic digests of DNA treated with cisplatin (cisDDP) in vitro now have been shown to be present in digested DNA originating from human… Expand
Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.
- F. J. Dijt, A. M. Fichtinger-Schepman, F. Berends, J. Reedijk
- Chemistry, Medicine
- Cancer research
- 1 November 1988
The formation and repair of cisplatin [cis-PtCl2(NH3)2] adducts in the DNA of cultured normal and repair-deficient human fibroblasts are presented in relation to cell survival after cisplatin… Expand
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.
- P. Bedford, A. M. Fichtinger-Schepman, S. Shellard, M. C. Walker, J. Masters, B. Hill
- Biology, Medicine
- Cancer research
- 1 June 1988
The formation and removal of four platinum-DNA adducts were immunochemically quantitated in cultured cells derived from a human bladder carcinoma cell line (RT112) and from two lines derived from… Expand
Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
- A. M. Fichtinger-Schepman, S. D. van der Velde-Visser, H. C. van Dijk-Knijnenburg, A. V. van Oosterom, R. Baan, F. Berends
- Medicine
- Cancer research
- 15 December 1990
During chemotherapy with a cisplatin-containing combination of drugs, 217 blood samples from 30 cancer patients were analyzed for the presence of the main cisplatin-DNA adduct cis-Pt(NH3)2d(pGpG)… Expand
Evidence of differential cisplatin‐DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines
- S. Shellard, A. M. Fichtinger-Schepman, J. Lazo, B. Hill
- Medicine
- Anti-cancer drugs
- 1 August 1993
The expression of intrinsic resistance to cisplatin in two lung cancer cell lines, one derived from a small cell carcinoma (SW1271) and the other from an adenocarcinoma (A549), relative to a… Expand
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
- B. Hill, S. Shellard, L. Hosking, A. M. Fichtinger-Schepman, P. Bedford
- Medicine
- International journal of radiation oncology…
- 1 July 1990
In vitro exposure of a human testicular teratoma continuous cell line to fractionated X-irradiation resulted in the expression of resistance to cisplatin. In two independently-derived sublines,… Expand
Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation.
- A. M. Fichtinger-Schepman, P. H. Lohman, J. Reedijk
- Biology, Medicine
- Nucleic acids research
- 11 September 1982
A method has been developed to determine the adducts formed upon interaction of cis- and trans-diamminedichloroplatinum(II) (cis- and trans-DDP) with DNA. After 5 h at 50 degrees C in the dark, the… Expand
Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells.
- F. A. Blommaert, H. C. van Dijk-Knijnenburg, +4 authors A. M. Fichtinger-Schepman
- Medicine
- Biochemistry
- 4 July 1995
We have studied the formation of adducts upon carboplatin treatment of isolated DNA and in cells. The major adduct formed in vitro, determined with atomic absorption spectroscopy and enzyme-linked… Expand
Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and…
- M. Treskes, L. Nijtmans, A. M. Fichtinger-Schepman, W. J. Van der vijgh
- Chemistry, Medicine
- Biochemical pharmacology
- 3 March 1992
The influence of the modulating agent WR2721, its active thiol-metabolite WR1065 and the symmetrical disulphide WR33278 on the in vitro formation and stability of cis-diamminedichloroplatinum(II)… Expand